Nomura Holdings Inc Astrazeneca PLC Transaction History

Nomura Holdings Inc

$70.8 Billion
Q4 2024

A detailed history of Nomura Holdings Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Nomura Holdings Inc holds 68,221 shares of AZN stock, worth $5.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

68,221

Previous 50,980 33.82%

Holding current value

$5.2 Million

Previous $3.97 Million 12.51%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $1.09 Million - $1.37 Million	17,241 Added 33.82%	68,221 $4.47 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $3.91 Million - $4.47 Million	50,980 New	50,980 $3.97 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $1.06 Million - $1.2 Million	-16,750 Reduced 51.14%	16,001 $1.11 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $632,684 - $822,105	11,671 Added 55.37%	32,751 $2.22 Million
Q3 2022 Nov 15, 2022	SELL	$53.02 - $135.75 $1.07 Million - $2.75 Million	-20,254 Reduced 49.0%	21,080 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $227,143 - $272,679	3,833 Added 10.22%	41,334 $2.77 Million
Q1 2022 May 18, 2022	SELL	$55.72 - $67.12 $668,640 - $805,440	-12,000 Reduced 24.24%	37,501 $2.52 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $594,220 - $702,130	-11,000 Reduced 18.18%	49,501 $2.88 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $2.46 Million - $2.69 Million	44,251 Added 272.31%	60,501 $3.61 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $351,045 - $436,305	7,250 Added 80.56%	16,250 $978,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $424,439 - $489,960	9,000 New	9,000 $450,000

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $236B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Astrazeneca PLC Transaction History